evaluating owl 2 reasoners in the context of clinical
play

Evaluating OWL 2 Reasoners in the context of Clinical Decision - PowerPoint PPT Presentation

Background LUCADA Evaluation Evaluating OWL 2 Reasoners in the context of Clinical Decision Support in Lung Cancer Treatment Selection M. Berkan Sesen Ernesto Jim enez-Ruiz Ren e Ba nares-Alc antara Sir Michael Brady Department


  1. Background LUCADA Evaluation Evaluating OWL 2 Reasoners in the context of Clinical Decision Support in Lung Cancer Treatment Selection M. Berkan Sesen Ernesto Jim´ enez-Ruiz Ren´ e Ba˜ nares-Alc´ antara Sir Michael Brady Department of Engineering Science Department of Computer Science Department of Oncology University of Oxford, UK 2nd OWL Reasoning Evaluation Workshop 22 July 2013

  2. Background LUCADA Evaluation Outline Background LUCADA Ontology Evaluation

  3. Background LUCADA Evaluation Background Lung Cancer Treatment • Lung cancer is responsible of the 21% of cancer-related deaths. • There are (substantial and unjustified) variations in treatment decisions between cancer centres. • Clinical guidelines (CGs) reduce variability in clinical practice. • Originally CGs are unstructured and free-text documents, and often not readily accessible at the point of decision making.

  4. Background LUCADA Evaluation Background Lung Cancer Treatment • Lung cancer is responsible of the 21% of cancer-related deaths. • There are (substantial and unjustified) variations in treatment decisions between cancer centres. • Clinical guidelines (CGs) reduce variability in clinical practice. • Originally CGs are unstructured and free-text documents, and often not readily accessible at the point of decision making.

  5. Background LUCADA Evaluation Background Lung Cancer Treatment • Lung cancer is responsible of the 21% of cancer-related deaths. • There are (substantial and unjustified) variations in treatment decisions between cancer centres. • Clinical guidelines (CGs) reduce variability in clinical practice. • Originally CGs are unstructured and free-text documents, and often not readily accessible at the point of decision making.

  6. Background LUCADA Evaluation Background Lung Cancer Treatment • Lung cancer is responsible of the 21% of cancer-related deaths. • There are (substantial and unjustified) variations in treatment decisions between cancer centres. • Clinical guidelines (CGs) reduce variability in clinical practice. • Originally CGs are unstructured and free-text documents, and often not readily accessible at the point of decision making.

  7. Background LUCADA Evaluation Background Clinical decision support (CDS) systems can. . . • facilitate the access to clinical guidelines. • computerise CGs using structured logical languages. • match guidelines rules against a patient record to infer the appropiate treatment. Examples • PROforma. Fox et al. (1997) • EON. Musen et al. (1996) • GLIF3. Want et al. (2004) • SAGE. Tu et al. (2007) • LUNG CANCER ASSISTANT . Berkan Sesen et al. (2012)

  8. Background LUCADA Evaluation Background Clinical decision support (CDS) systems can. . . • facilitate the access to clinical guidelines. • computerise CGs using structured logical languages. • match guidelines rules against a patient record to infer the appropiate treatment. Examples • PROforma. Fox et al. (1997) • EON. Musen et al. (1996) • GLIF3. Want et al. (2004) • SAGE. Tu et al. (2007) • LUNG CANCER ASSISTANT . Berkan Sesen et al. (2012)

  9. Background LUCADA Evaluation Background Lung Cancer Assistant (LCA) • An ontology-based system which provides guideline rule-based decision support for lung cancer treatment. • LCA exploits the English Lung Cancer Dataset ( LUCADA ) LUCADA ontology • LUCADA has been built using the OWL 2 language. • Represents the semantic layer of the LCA: • Captures the domain in the LUCADA dataset. • Encodes the clinical guidelines . • Represents patient data .

  10. Background LUCADA Evaluation Background Lung Cancer Assistant (LCA) • An ontology-based system which provides guideline rule-based decision support for lung cancer treatment. • LCA exploits the English Lung Cancer Dataset ( LUCADA ) LUCADA ontology • LUCADA has been built using the OWL 2 language. • Represents the semantic layer of the LCA: • Captures the domain in the LUCADA dataset. • Encodes the clinical guidelines . • Represents patient data .

  11. Background LUCADA Evaluation Outline Background LUCADA Ontology Evaluation

  12. Background LUCADA Evaluation LUCADA Ontology Example of guideline rule • Eligibility criteria are encoded as equivalence axioms. • “Consider radiotherapy for Stage I, II, III patients with good performance status” RT GR ≡ GoodPerformancePatient ⊓ ∃ hasClinicalFinding . (NeoplasticDisease ⊓ ∃ hasPreHistology . NonsmallCellCarcinoma ⊓ ∃ hasPreTNMStaging . string ⊓ ∀ hasPreTNMStaging . { I , II , III } )

  13. Background LUCADA Evaluation LUCADA Ontology Example of patient • Each patient is encoded with ∼ 25 individual axioms.

  14. Background LUCADA Evaluation LUCADA Ontology Integration with SNOMED CT • SNOMED is the reference ontology in the National Health Service (NHS). • To facilitate interoperability we have integrated LUCADA with SNOMED. • We have used LogMap matching system to • identify the classes in SNOMED related to LUCADA. • extract a lung cancer-specific module of SNOMED CT.

  15. Background LUCADA Evaluation LUCADA Ontology Summary of LUCADA and LUCADA-SNOMED metrics Ontology LUCADA-SNOMED LUCADA Metric DL Expressivity ALCHIF ( D ) ALCHI ( D ) # Classes 1553 376 # Object properties 63 37 # Data Properties 63 63 # Equiv. class axioms 1050 40 # Subclass of axioms 999 386 # Prop. domain axioms 97 97 # Prop. range axioms 30 30

  16. Background LUCADA Evaluation Outline Background LUCADA Ontology Evaluation

  17. Background LUCADA Evaluation Evaluation Evaluation settings • Windows 7 64-bit desktop computer, • 15 GiB of RAM, and • Intel Xeon 2.27 GHz CPU. • Results have been calculated as average of at least 10 repetitions of the experiment.

  18. Background LUCADA Evaluation Evaluation Evaluated Reasoners • HermiT 1.3.7, Pellet 2.3.0 and FaCT++ 1.6.2 Experiments • Increasing the TBox with guideline rules or patient scenarios. • Increasing the ABox with patient records.

  19. Background LUCADA Evaluation Evaluation Experiment 1: Increasing the TBox with guideline rules • 1 to 40 patient scenarios or guideline rules. • With LUCADA and LUCADA-SNOMED with 1 patient. • Recorded times for classification and realisation.

  20. Background LUCADA Evaluation Experiment 1 (increasing TBox) with LUCADA 250 250 FaCT++ (total) Pellet (total) HermiT (classification) HermiT (realisation) 200 200 150 150 Time (ms) 100 100 50 50 0 0 5 10 15 20 25 30 35 40 Number of patient scenarios

  21. Background LUCADA Evaluation Experiment 1 (increasing TBox) with LUCADA-SNOMED FaCT++ (total) Pellet (total) 50000 50000 HermiT (classification) HermiT (realisation) 40000 40000 9000 9000 Time (ms) 7000 7000 5000 5000 3000 3000 1000 1000 5 10 15 20 25 30 35 40 Number of patient scenarios

  22. Background LUCADA Evaluation Evaluation Experiment 2: Increasing the ABox with patient records • 1 to 100 patient records. • Experiment with LUCADA with 40 patient scenarios. • Recorded times for realisation of all patients.

  23. Background LUCADA Evaluation Experiment 2 (increasing ABox) with LUCADA 70000 70000 FaCT++ Pellet HermiT 60000 60000 50000 50000 40000 40000 Time (ms) 30000 30000 20000 20000 10000 10000 0 0 0 20 40 60 80 100 Number of patients

  24. Conclusions from the LCA experiments • FaCT++ is currently the best choice for LCA. • HermiT provides the fastest TBox reasoning for LUCADA-SNOMED CT. • HermiT does not scale for ABOX reasoning with LUCADA. • Pellet performs well in classifying the LUCADA. • Pellet struggles with the LUCADA-SNOMED CT ontology.

  25. Questions? • Lung Cancer Assistant (LCA): http://lca.eng.ox.ac.uk/LungCancerSmartGWT/ • LCA’s main contact: Berkan Sesen (berkan.sesen@eng.ox.ac.uk) • Tests and LUCADA-SNOMED integration: Ernesto Jimenez Ruiz (ernesto.jimenez.ruiz@gmail.com) Thank you for your attention Acknowledgements • The LCA project was funded by the CDT in Healthcare Innovation programme within the Institute of Biomedical Engineering, Oxford University.

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend